Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Membrane Proteins”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05687266
What this trial is testing

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

Who this might be right for
NSCLC
AstraZeneca 1,350
Early research (Phase 1)Study completedNCT02661373
What this trial is testing

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Who this might be right for
Malaria
St. Jude Children's Research Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT01353638
What this trial is testing

Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis

Who this might be right for
End Stage Renal Disease
Christoph Aufricht 25
Not applicableStudy completedNCT00735059
What this trial is testing

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Who this might be right for
Chronic Kidney Disease
EXcorLab GmbH 14
Early research (Phase 1)Study completedNCT04542382
What this trial is testing

Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)

Who this might be right for
Healthy Volunteers
University of California, San Francisco 11
Post-approval studies (Phase 4)Ended earlyNCT04059458
What this trial is testing

Mandibular Furcation III Regeneration (FURC-III-REGEN)

Who this might be right for
Furcation DefectsPeriodontal Diseases
University of Oslo 5
Not applicableLooking for participantsNCT06214507
What this trial is testing

Danon Disease Natural History Study

Who this might be right for
Danon Disease
Rocket Pharmaceuticals Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Not applicableStudy completedNCT00624689
What this trial is testing

Effects of Milk Fat Globule Membrane (MFGM) - Enriched Formula With Reduced Energy and Protein Content on Growth and Development

Who this might be right for
Infant
Umeå University 240
Not applicableStudy completedNCT00638521
What this trial is testing

Immune-cell Membrane Trafficking

Who this might be right for
Severe Trauma
University of Washington 213
Large-scale testing (Phase 3)Looking for participantsNCT07291037
What this trial is testing

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 400
Testing effectiveness (Phase 2)Study completedNCT00870987
What this trial is testing

Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malaria

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 82
Not applicableStudy completedNCT07836881
What this trial is testing

Effects of Supervised Exercise Training on Erythrocyte Deformability in Hemodialysis Patients

Who this might be right for
End-Stage Renal Disease Requiring Haemodialysis
Asia University 63
Early research (Phase 1)Study completedNCT02851277
What this trial is testing

Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Who this might be right for
Peanut Allergy
Astellas Pharma Global Development, Inc. 31
Not applicableStudy completedNCT02615951
What this trial is testing

Characterization of Breg Cells

Who this might be right for
Healthy VolunteersArthritis, Rheumatoid
University Hospital, Montpellier 100
Early research (Phase 1)Study completedNCT03755713
What this trial is testing

Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

Who this might be right for
Peanut Allergy
Astellas Pharma Global Development, Inc. 20
Not applicableStudy completedNCT00371241
What this trial is testing

Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO

Who this might be right for
Persistent Fetal Circulation SyndromeDiaphragmatic HerniaMeconium Aspiration+1 more
The University of Texas Health Science Center, Houston 12
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Ended earlyNCT04455815
What this trial is testing

A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)

Who this might be right for
COVID-19 Infection
Cancer Research UK 34
Early research (Phase 1)Study completedNCT01707069
What this trial is testing

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Who this might be right for
Allergic Rhinoconjunctivitis
Immunomic Therapeutics, Inc. 24
Next Page